What is KeyCorp’s Estimate for Plexus FY2026 Earnings?

Plexus Corp. (NASDAQ:PLXSFree Report) – Stock analysts at KeyCorp issued their FY2026 EPS estimates for Plexus in a research report issued to clients and investors on Monday, September 21st. KeyCorp analyst S. Barger expects that the technology company will earn $7.18 per share for the year. KeyCorp currently has a “Overweight” rating and a $300.00 target price on the stock. The consensus estimate for Plexus’ current full-year earnings is $7.11 per share. KeyCorp also issued estimates for Plexus’ Q4 2026 earnings at $2.29 EPS, Q1 2027 earnings at $2.01 EPS, Q2 2027 earnings at $2.10 EPS, Q3 2027 earnings at $2.27 EPS, Q4 2027 earnings at $2.35 EPS and FY2027 earnings at $8.74 EPS.

Plexus (NASDAQ:PLXSGet Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating the consensus estimate of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm’s revenue was up 28.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS.

Several other research analysts have also recently weighed in on PLXS. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective for the company in a research report on Friday, July 31st. Weiss Ratings lowered Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, September 9th. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Stifel Nicolaus boosted their target price on Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $310.00 price target on shares of Plexus in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $276.86.

Check Out Our Latest Analysis on PLXS

Plexus Stock Performance

PLXS opened at $263.90 on Thursday. The business’s 50-day moving average price is $252.51 and its two-hundred day moving average price is $250.33. Plexus has a 1 year low of $132.03 and a 1 year high of $307.06. The company has a market capitalization of $7.06 billion, a price-to-earnings ratio of 38.92 and a beta of 0.89. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72.

Institutional Investors Weigh In On Plexus

Several large investors have recently made changes to their positions in PLXS. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Plexus in the second quarter valued at $32,000. Kilter Group LLC acquired a new position in shares of Plexus during the 2nd quarter worth about $40,000. Integrated Wealth Concepts LLC acquired a new position in shares of Plexus during the 2nd quarter worth about $51,000. Persistent Asset Partners Ltd bought a new stake in shares of Plexus in the 2nd quarter valued at about $71,000. Finally, Covestor Ltd raised its holdings in shares of Plexus by 207.7% in the 4th quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after purchasing an additional 162 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Insider Activity

In other news, Director Karen Rapp sold 500 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the completion of the transaction, the director owned 7,535 shares in the company, valued at $1,814,955.45. This trade represents a 6.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd Kelsey sold 1,500 shares of the company’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the sale, the chief executive officer owned 65,888 shares in the company, valued at $16,536,570.24. The trade was a 2.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,500 shares of company stock worth $1,960,520 in the last quarter. Corporate insiders own 1.78% of the company’s stock.

About Plexus

(Get Free Report)

Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.

Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

Featured Articles

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.